Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Accumulated Depreciation (2018 - 2021)

Tenax Therapeutics' Accumulated Depreciation history spans 4 years, with the latest figure at $753241.0 for Q1 2016.

  • On a quarterly basis, Accumulated Depreciation changed N/A to $753241.0 in Q1 2016 year-over-year; TTM through Mar 2016 was $753241.0, a N/A change, with the full-year FY2015 number at $748604.0, changed N/A from a year prior.
  • Accumulated Depreciation hit $753241.0 in Q1 2016 for Tenax Therapeutics, up from $748604.0 in the prior quarter.
  • Over the last five years, Accumulated Depreciation for TENX hit a ceiling of $753241.0 in Q1 2016 and a floor of -$893194.0 in Q1 2014.
  • Historically, Accumulated Depreciation has averaged -$423123.6 across 4 years, with a median of -$849986.0 in 2013.
  • Biggest five-year swings in Accumulated Depreciation: fell 0.43% in 2014 and later surged 186.24% in 2015.
  • Tracing TENX's Accumulated Depreciation over 4 years: stood at -$872543.0 in 2013, then decreased by 0.23% to -$874558.0 in 2014, then skyrocketed by 185.6% to $748604.0 in 2015, then grew by 0.62% to $753241.0 in 2016.
  • Business Quant data shows Accumulated Depreciation for TENX at $753241.0 in Q1 2016, $748604.0 in Q4 2015, and $717379.0 in Q2 2015.